Published

Acute psilocin increased cortical activity in rat

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Frontiers in Neuroscience
Date: 2026-02-04
Source: Crossref
DOI: 10.3389/fnins.2026.1593703
PubMed: 41716660

Authors

Liu Junhong Wang Yuanyuan Xia Ke Wu Jinfeng Zheng Danhao Cai Aoling Yan Haitao Su Ruibin

Watch author

Derived topics and classifications

psilocybin psilocin Depression Brain Imaging Mechanism of Action Aging Clinical Trial Animal Study Clinical Trial

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1038/s41467-019-13575-7 10.1016/s0197-0186(96)00136-2 10.3389/fnbeh.2015.00363 10.1038/s41593-018-0195-0 10.1016/j.neuron.2007.11.008 10.1038/d41586-022-00767-3 10.1016/s2215-0366(16)30065-7 10.1177/0269881117725915 10.1038/s41598-017-13282-7 10.1371/journal.pone.0116686 10.3389/fnbeh.2017.00112 10.1016/s0301-0082(96)00033-0

Indexed papers citing this DOI

Acute psilocin increased cortical activity in rat2026-02-04

Related papers

Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe AnxietyClinicalTrials.gov · 2026-07-23 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)ClinicalTrials.gov · 2026-07-30 PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-07-10 Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic EffectsClinicalTrials.gov · 2026-07-09 A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-06-25